{"DataElement":{"publicId":"2347","version":"3","preferredName":"ER Assay Performed Time","preferredDefinition":"provide point during course of the disease when the assay was performed.","longName":"ER_ASSAY_PERF_TM","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2189052","version":"1","preferredName":"ER Assay Performed","preferredDefinition":"information related to ER assay performed.","longName":"ER_ASSAY_PERF","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206632","version":"1","preferredName":"ER Assay","preferredDefinition":"Widely expressed human Estrogen Receptors (NR3 Family) are ligand-activated nuclear hormone receptor transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI):A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. (from MSH98)","longName":"C17069:C16341","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Family","conceptCode":"C17069","definition":"Widely expressed human Estrogen Receptors (NR3 Family) are cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bioassay","conceptCode":"C16341","definition":"A laboratory test or analysis of the biological activity of a substance performed by studying its effect on an organism or in a test tube under controlled conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FD73-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177693","version":"1","preferredName":"Performed","preferredDefinition":"Executed and carried through to completion. (NCI)","longName":"Performed","context":"SPOREs","contextVersion":"2.31","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCFF8B96-1D08-69F3-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-06","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-06","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Added Concept Code AA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5DE9527-6680-31B3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019267","version":"1","preferredName":"Assay Performed Time","preferredDefinition":"the timing of the performance of an assay.","longName":"ASSAY_PERF_TM","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184344","version":"1","preferredName":"Time","preferredDefinition":"Time is the continuum of experience in which events pass from the future through the present to the past.","longName":"Time","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Time","conceptCode":"C25207","definition":"The continuum of experience in which events pass from the future through the present to the past.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-211A-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EB3197-4E5A-4257-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-09-09","modifiedBy":"CAMPBELB","dateModified":"2004-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811964","version":"1","longName":"Tumor Markers","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811716","version":"1","longName":"UC Irvine","context":"NCIP"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"ER Timing, Other, Specify","type":"Preferred Question Text","description":"ER Timing, Other, Specify","url":null,"context":"CTEP"},{"name":"COMMENT_171","type":"COMMENT","description":"Add instruction to template form: If,","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Other, specify","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C6EB2085-9E3C-43DC-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-09","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-09-09","modifiedBy":"REEVESD","dateModified":"2013-05-29","changeDescription":"ISO 11179 Compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}